Terpenoid Therapeutics closes Series A financing - MarketLine Financial Deals

Terpenoid Therapeutics closes Series A financing

Terpenoid Therapeutics closes Series A financing - MarketLine Financial Deals
Terpenoid Therapeutics closes Series A financing
Published Jan 25, 2010
2 pages — Published Jan 25, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Terpenoid Therapeutics, Inc., a US-based drug discovery and development company focused on anti-cancer therapeutics, has secured $1.5 million in Series A financing led by Iowa First Capital Fund II, L.P.

  
Source:
Document ID
MA49582_110208
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Terpenoid Therapeutics closes Series A financing" Jan 25, 2010. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Terpenoid-Therapeutics-closes-Series-A-financing-2052-52741>
  
APA:
MarketLine Financial Deals. (2010). Terpenoid Therapeutics closes Series A financing Jan 25, 2010. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Terpenoid-Therapeutics-closes-Series-A-financing-2052-52741>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.